| |
Target Audience
Nurse Practitioners and Physician Assistants
Program Objectives
• Review recent clinical study results and guidelines and their application in primary care
• Examine the latest diagnostic and treatment strategies for common conditions encountered in the primary care setting
• Apply new data to clinical case reports to enhance practice performance and improve patient outcomes
Accreditation Information
 Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Contact Hours: 7.5.
 This program has been reviewed and is approved for a maximum of 7.5 hours of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Approval is valid for 1 year from the issue date of August 11, 2010. Participants may submit the self-assessment at any time during that period.
This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
Continuing Nursing Education Provider Unit, Boston University School of Medicine’s provider status refers only to continuing nursing education activities and does not imply that there is real or implied endorsement of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.
This program was supported by educational grants from Abbott Laboratories, Amgen Inc., Astellas Pharmaceuticals, Inc., Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Endo Pharmaceuticals, Merck & Co., Inc., and Novo Nordisk.
Practicing Clinicians Exchange gratefully acknowledges the Centers for Disease Control and Prevention (CDC), DIME, Global Directions in Medicine, Miller Medical Communications, and the National Osteoporosis Foundation for their contributions as education partners for this program.
Practicing Clinicians Exchange Mission Statement
Practicing Clinicians Exchange (PCE) is an innovative national educational initiative designed specifically for nurse practitioners (NPs) and physician assistants (PAs). PCE’s premier series of live, national CE/CME symposia and other educational activities revolve around challenges NPs and PAs face most often in clinical practice. To ensure that you receive all of our educational activities, including live programs in your area or national home study activities, please register at: www.practicingclinicians.com. PCE is a division of Continuing Education Alliance.
Disclaimer
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the American Academy of Physician Assistants, Boston University, Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
Disclosures
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CE/CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices is being discussed. This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration.
Unlabeled/investigational uses of commercial products are discussed in the following activity: Treating T2DM With GLP-1 Agonists: A Patient-Centric Perspective.
Dr Altus has nothing to disclose with regard to commercial interests.
Dr Alukal has nothing to disclose with regard to commercial interests.
Dr Bruckenthal: consultant: Ameritox, Cephalon, Inc., Endo Pharmaceuticals.
Dr Cobble: consultant: Abbott Laboratories, AstraZeneca, Eli Lilly and Company; research grants: Abbott Laboratories; speakers bureau: Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline, Novo Nordisk.
Dr Gray: speakers bureau: Pfizer Inc, Sage Products, Inc.
Mr Herman has nothing to disclose with regard to commercial interests.
Dr Knudtson: consultant: Procter & Gamble; speakers bureau: Ortho-McNeil-Janssen Pharmaceuticals.
Dr Kucera: consultant: Medicis Pharmaceutical Corporation; speakers bureau: Abbott Laboratories, Amgen Inc., Centocor Ortho Biotech Inc., Warner Chilcott.
Dr Nichol: consultant: GlaxoSmithKline, Wyeth; research grants: Sanofi Pasteur.
Dr Watts: consultant: Amgen Inc., Baxter, Eli Lilly and Company, InteKrin Therapeutics Inc., Johnson & Johnson Services, Inc., Mannkind Corporation, Novartis, Novo Nordisk, Procter & Gamble, sanofi-aventis, Takeda Pharmaceutical Company Limited; honoraria: Amgen Inc., Novartis, Procter & Gamble, sanofi-aventis; research grants: Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Novartis, NPS Pharmaceuticals, Procter & Gamble.
Dr Zimmerman: consultant/research grants: MedImmune LLC, Merck & Co., Inc.
The Planning Committee for this activity included Patti-Ann Collins, MSN, MBA, RN, Ilana Hardesty, of Boston University; Carol Friedman, DO, of Centers for Disease Control and Prevention; Nancy Baxter and Natasha A. Mitchner, PhD, of DIME; Lyerka Miller, PhD, of Miller Medical Communications; Susan K. Randall, MSN, FNP-BC, and Audrey E. Shively, MSHES, CHES, of National Osteoporosis Foundation; and Ruth Cohen, Dominic Francese, Grace Halsey, and Christine M. Olsen, PhD, of Practicing Clinicians Exchange. The members of the Planning Committee have no significant relationships to disclose.
*Treating T2DM With GLP-1 Agonists: A Patient-Centric Perspective was recorded on June 12, 2010, in Cary, North Carolina.
|
|
